177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
Clinical trial NCT04903899 · RECRUITING
Trial details
- NCT number
- NCT04903899
- Sponsor
- Jakob Stenman
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-19
- Primary completion
- 2026-05-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.